Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children
Clinical trial NCT04444284 · COMPLETED
Trial details
- NCT number
- NCT04444284
- Sponsor
- Meissa Vaccines, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-05-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.